Remdesivir Gets FDA Approval, but WHO Says Drug Ineffective for COVID
Gilead’s remdesivir projected to generate $3 billion in sales for the upcoming year — but the WHO says the drug has no benefit.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
